{
  "name" : "dacemirror.sci-hub.se_journal-article_772ea31e8bff422db5dce05f61296e46_liu2017.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "The Effects of Physicochemical Properties of Nanomaterials on Their Cellular Uptake In Vitro and In Vivo",
    "authors" : [ "Ye Liu", "Bereket Workalemahu", "Xingyu Jiang" ],
    "emails" : [ "xingyujiang@nanoctr.cn" ],
    "sections" : [ {
      "heading" : null,
      "text" : "1701815 (1 of 13) © 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim\nreview www.small-journal.com small\nThe Effects of Physicochemical Properties of Nanomaterials on Their Cellular Uptake In Vitro and In Vivo"
    }, {
      "heading" : "Ye Liu, Bereket Workalemahu, and Xingyu Jiang*",
      "text" : "Prof. Y. Liu, Dr. B. Workalemahu, Prof. X. Jiang Beijing Engineering Research Center for BioNanotechnology CAS Key Laboratory for Biological Effects of Nanomaterials and Nanosafety CAS Center for Excellence in Nanoscience National Center for NanoScience and Technology No. 11 Zhongguancun Beiyitiao, Beijing 100190, P. R. China E-mail: xingyujiang@nanoctr.cn Prof. X. Jiang Sino-Danish College University of Chinese Academy of Sciences Beijing 100049, P. R. China\nDOI: 10.1002/smll.201701815"
    }, {
      "heading" : "1. Introduction",
      "text" : "Nanomaterials (NMs)/technologies are receiving increasing attentions from various research fields including biomedicine,[1,2] electronics,[3] catalysis,[4] and materials engineering.[5] Especially, the unique properties of NMs, such as large surface area, tunable functional modifications, effective target-delivery, and controllable self-assembly, endow them many new functions that have shown great potential for satisfying several advanced biomedical applications. For example, several engineered NMs have been developed as highly sensitive biosensors,[6] organtargeted drug carriers,[7,8] and polyfunctional immunological adjuvants.[9–11] Since cells are the elementary unit to construct various organisms, once NMs enter the body, one of the fundamental questions is how NMs interact with cells. For a long time, researching the interactions between NMs and cells is a focused and inevitable issue in the intersectant research area between NMs and biomedicine. Abundant studies have shown that several physicochemical properties of NMs including size, shape, rigidity, and surface modification play critical roles in determining the interactions between NMs and cells.[12] Such NMs–cells interactions will significantly affect a wide range of NMs cellular behaviors, including NMs–cell attachment, NMs cellular uptake, NMs trafficking, and localization inside cells.[13]\nAmong all these cellular behaviors, NMs cellular uptake is a basic premise to realize various biomedical applications of NMs.\nUnderstanding the cellular uptake of nanomaterials (NMs) is a fundamental and critical issue for uncovering biomedical effects of NMs and facilitating their practical applications in the clinic. In this Review, by highlighting the differences of NMs cellular uptake between in vitro and in vivo, a focus on reviewing recent works about the effects of four physicochemical parameters of NMs (size, rigidity, shape, surface modification) on regulating NMs cellular uptake in vitro and in vivo is undertaken. This review can provide readers some useful clues and new thinking for understanding NMs cellular uptake in depth.\nNanomaterials\nAlong with the growing importance of the biomedical applications of NMs, in recent years, the studies aiming at NMs cellular uptake show an explosive growth.[14] For example, developing new methods to quantify NMs cellular uptake has become an important research direction.[15] Highcontent analysis based fluorescencelabeling technology provides quantitative multiparametric intracellular fluorescence data to analyze NMs uptake.[15] Moreover, how to enhance NMs cellular uptake effi-\nciency is another hot topic. In this respect, multiple targetspecific ligands modification strategy shows a great potential to enhance the cellular uptake efficiency of modified NMs.[16] Although fruitful achievements have been obtained, there are still many difficulties in the process of understanding NMs cellular uptake. A major challenge we faced now is how to quantitatively analyze NMs cellular uptake in vivo, or accurately find out the relevance of NMs cellular uptake between in vitro and in vivo.[17]\nHerein, we review the critical physicochemical parameters of NMs on regulating their cellular uptake in vitro and in vivo, and expect to be capable of explaining the relevance of NMs cellular uptake between in vitro and in vivo. Due to the fundamental nature to govern NMs cellular uptake and the universal principles to guide NMs applications in biomedicine, reviewing these works, we think, is important to find out the crucial clues or provide some new thinking to understand NMs cellular uptake in depth."
    }, {
      "heading" : "2. Basic Cognition for Researching NMs Cellular",
      "text" : "Uptake In Vitro and In Vivo\nUp to now, most studies of NMs cellular uptake are achieved based on in vitro cell models. Indeed, in vitro model possesses its advantages on straightforwardly observing the process of NMs uptake, accurately quantifying intracellular NMs, precisely controlling NMs uptake behaviors at the single cell level.[13,15] However, the significant inconsistency between in vitro and in vivo microenvironments, in many cases, greatly discounts the value of in vitro models on guiding the research and application of NMs. On the contrary, although in vivo models can truthfully respond NMs cellular uptake, in vivo models fail to provide enough information to uncover NMs cellular uptake in depth due to the limitation of methodology and the complexity of in vivo microenvironment.[17] Therefore, how to reasonably integrate advantages of both models and accurately find out the relevance of NMs cellular uptake between in vivo and in vitro become the critical issues in the research field of NMs cellular uptake.\nSmall 2017, 1701815\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1701815 (2 of 13)\nIn order to effectively answer above-mentioned questions, we first need know what happens to NMs once they enter the body? Generally speaking, NMs would not remain stable in the complex in vivo environments, and tend to bind or adsorb vari ous biological proteins or molecules to form a surface coating. In other words, we should conceptually consider in vivo NM as a complex hybrid with an inorganic/organic core and a biologic surface coating.[18,19] Therefore, in the in vivo microenvironme\ncal features of NMs, defined as biological identity of NMs.[21]\nSecond, understanding the difference among various cells is also very important for the investigation of NMs cellular uptake. Different types of cells have significantly different capability to uptake NMs. For example, based on cell-culturing studies, it is well known that almost mammalian cells can engulf various NMs with different physicochemical properties to some extent depending on various uptake mechanisms and behaviors, but similar NMs uptake behaviors are yet not routinely necessary for other types of nonmammalian cells.[22] Moreover, some professional antigen-presenting cells such as dendritic cells are powerful for quickly capturing and internalizing NMs even under a high blood flow in vivo, whereas other types of cells such as epithelial cells show very poor capacity to uptake the same NMs.[22] The difference of NMs uptake also appears in the case of monocytes and macrophages. Monocytes preferentially internalize bare nanoparticles, whereas macrophages tend to engulf nanoparticles at the same rate regardless of a protein corona (PC).[23] All these results suggest that we should employ different standards to investigate NMs cellular uptake according to the difference among cell types.\nThird, it also should be noted that various cellular uptake mechanisms will increase the complexity for investigating NMs cellular uptake. For example, red blood cells do not have any phagocytic receptors and actin–myosin on their surface, and thereby cannot internalize NMs via phagocytosis.[24] By contrast, professional phagocytes like dendritic cells, neutrophils, and monocytes/macrophages have phagocytic receptors and actin–myosin on their surface to mediate NMs cellular uptake via various mechanisms including macropinocytosis, clathrinmediated endocytosis, caveolin-mediated endocytosis, clathrin/ caveolin-independent endocytosis, and phagocytosis.[25] Up to now, using pharmacological substances to inhibit specific cellular uptake pathways is a widely acceptable way to uncover the mechanisms of NMs cellular uptake.[26] In this respect, abundant reports have described the detailed mechanisms of NMs cellular uptake in a wide range of cell types (brain cells, epitelial cells, and cancer cells), and greatly facilitate our understanding of NMs cellular uptake.[25,27–29]\nMoreover, different administration routes (intravenous, intramuscular, inhalation, ingestion, and cutaneous) determine the specificity of in vivo microenvironment where NMs come to contact, and significantly affect NMs cellular uptake in the site of administration. For example, inhalation administration (lung-target) is totally different from intravenous injection (liver-target) for determining NMs cellular uptake in vivo. For NMs inhalation administration, NMs cellular uptake can be affected by size, shape, and surface properties.[30] NMs with a sufficiently small size (<100 nm) can more efficiently traverse the surfactant layer and are internalized by lung epidermic cells in comparison with larger nanoparticles.[31] Rod-shaped nanoparticles show a significantly higher cellular uptake than disk and/or barrel shapes.[32] NMs surface modified with hydrophobic molecules get entangled in the surfactant layer, thereby reducing their final cellular uptake. By contrast, their hydrophilic partners have a more efficient cellular uptake might due to a quick traverse through the surfactant layer.[33] However, for NMs intravenous injection (titanium-based nanoparticles\nYe Liu is an associate professor at the Key Laboratory for Biological Effects of Nanomaterials and Nanosafety in the National Center for Nanoscience and Technology of China. His research interests include developing nanomaterials as adjuvant to optimize vaccinetriggered immunity, using nanomaterial/technology to\ndiagnose diseases, the immunoregulation mechanism of nanomaterials, and the effects of nanomaterials on modulate cell behaviors.\nBereket Workalemahu received his B.Sc. degree in Medical Laboratory Technology and M.Sc. degree in Medical Microbiology at Jimma University, Ethiopia. He joined the Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia to work on Molecular Biology, Microbiology, and Immunology of infectious\ndiseases under the guidance of Prof. Abraham Aseffa. He also served as a researcher and lecturer of Medical Microbiology at Arba Minch College of Health Sciences (ACHS). Currently, he is a CAS-TWAS Ph.D. fellow at the National Center for Nanoscience and Technology (NCNST), Beijing, China, studying Nanomedicine under the supervision of Prof. Xingyu Jiang.\nXingyu Jiang obtained his B.S. at the University of Chicago (1999), followed by an AM (2001) and a Ph.D. (2004) from Harvard University, working with Prof. George Whitesides. He joined the NCNST in 2005 as a professor in the National Center for Nanoscience and Technology of China. Xingyu’s research interests include\nnanomaterials as vector/immunoregulators for vaccines and drugs, surface chemistry, and microfluidics.\nSmall 2017, 1701815\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1701815 (3 of 13)\nas examples), they usually have a rapid uptake by cells in the liver through the systemic circulation, regardless of the single or repeated administrations.[34,35] By comparing with the cellular uptake of NMs with different sizes and compositions via intravenous injection in male Wistar rats, researchers find that both anatase-rutile TiO2 NMs (20–30 nm) and rutile TiO2 NMs (200 nm) will focus on distributing in the liver. No significantly different cellular uptake between anatase-rutile TiO2 NMs and rutile TiO2 NMs are detected in liver.[36] Together, the effects of NMs physicochemical properties on their cellular uptake in vivo will show some differences by different NMs administration routes.\nAt last, we think developing new or advanced technologies that can quantitatively and real-time analyze NMs cellular uptake in vivo is the fundamental solution to overcome existing bottlenecks in the research field of NMs cellular uptake. Although it is still lacking a mature method to precisely analyze NMs cellular uptake in vivo so far, several technologies are showing their potential in real-time tracing and quantitatively analyzing NMs cellular uptake in vivo. Radioactive labeling has the unique advantage on detecting absolute cellular uptake amounts of NMs[37–39] and start some applications on tracing the cellular uptake of Au-based and Fe-based NMs in vivo.[40–42] X-ray and magnetic resonance imaging (MRI), due to their satisfactory penetrating capacity, show great values in detecting NMs cellular uptake happening in a relatively deep location in vivo, although they are limited to analyze some specific-properties NMs such as NMs composed of element with large atomic number (metal, iodine) or magnetic NMs (ferric oxide).[37–39] Fluorescence-labeling is another promising method to analyze NMs cellular uptake in vivo due to its quantitative capability and easily observed colorful imaging, even suffering the limitation of weak penetrating capacity in vivo.[37–39]\nOverall, the investigation of NMs cellular uptake based on in vitro models is discounted due to its lacking to respond actual situations. By contrast, the investigation of NMs cellular uptake based on in vivo models can only offer limited information because of the limitation of methodology. Such current situation requires us, in the process of researching NMs cellular uptake, to reasonably integrate both in vivo and in vitro models and accurately explore the relevance of NMs cellular uptake between in vivo and in vitro."
    }, {
      "heading" : "3. Protein Corona: A Critical Factor to Cause the Difference of NMs Cellular Uptake between",
      "text" : "In Vitro and In Vivo\nBefore we investigate NMs cellular uptake, in particular under complex physiological conditions, it is necessary to be aware of the importance of the existence of PC. PC is usually defined as the biomolecule layer coated around NMs surface. Once NMs enter physiological environments (such as blood), the biotransformation on NMs surface will inevitably occur. Due to the high surface free energy of NMs, NMs exposed to physiological environments[43–45] will cause nonspecific adsorption of proteins onto NMs surface[46] via different binding forces such as electrostatic interactions, π–π stacking, hydrophobic interactions,\nvan der Waals force, and hydrogen bonds.[13,47] The properties of PC-covered NMs will significantly change, in most cases, compared with the essential physicochemical properties of naked NMs.[21,46,48] Hence, NMs should no longer be viewed as homogeneous entities, but should be considered as inorganic/ organic–biological nanohybrids with complex compounds.\nActually, multiple studies have shown that PC will change the interactions between NMs and cell membrane, finally affecting NMs cellular uptake.[49–52] Usually, PC-coated NMs require some cellular receptors to help them to achieve cellular uptake.[53] Furthermore, the correlation between the amount of proteins/molecules covered on NMs and the efficacy of NMs cellular uptake has also been quantitatively analyzed.[54] Moreover, a case shows that the formation of PC in serums can increase DNA transfection efficacy of cationic liposomes because PC changes the route of NMs cellular uptake via the clathrin and/or caveolae-mediated endocytocis to increase DNA transfection efficiency.[55] All these results have provided us the direct evidence to fully demonstrate that PC can affect the interactions between NMs and cells and NMs cellular uptake. However, how to understand in-depth PC-mediated regulation of NMs cellular uptake is still far from being understood. Herein, we will try to explain this question based on that PC affects the critical physicochemical properties of NMs (size, rigidity, shape, surface modification) to regulate NMs cellular uptake."
    }, {
      "heading" : "4. Size",
      "text" : "The size of NMs plays an important role in affecting NMs cellular uptake via regulating the interactions between NMs and cells.[56–61] Indeed, several studies about NMs cellular uptake in vitro suggest that various protein supplements in the cell culture media will also yield significantly different PC and interfere in the size of NMs, finally affecting their cellular uptake.[62,63] According to the membrane-wrapping process mode, size-dependent interactions between NMs and cells are related to the process of membrane wrapping. Such membrane-wrapping process initiates receptor-mediated endocytosis that requires the concerted formation of multiple interactions between NMs and cell membrane receptors.[64,65] The size of NMs, to a larger extent, determines the contact area and contact pattern between NMs and cell membrane.[61] The contact area and contact pattern will further affect NMs cellular uptake. Actually, NMs cellular uptake is a very complex process and involves various uptake pathways. One of the most known pathways is phagocytosis which is defined as a process where phagocytes engulf solid NMs to form internal compartments to realize NMs cellular uptake.[61] Moreover, several nonphagocytic pathways, such as clathrin-mediated endocytosis, caveolaemediated endocytosis, and macropinocytosis, also play the roles in mediating NMs cellular uptake.[66–68] All these mechanisms will comprehensively affect the cellular uptake efficiency and kinetics of NMs.\nOptimizing the size of NMs can significantly increase NMs cellular uptake. Several of our previous works have focused on understanding the corrections between the size of NMs and their cellular uptake. The results show that ≈100 nm size is favorable to NMs cellular uptake (Figure 1). We used a\nSmall 2017, 1701815\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1701815 (4 of 13)\nmicrofluidic origami chip with various 3D geometries to synthesize monodisperse functionalized poly(lacticcoglycolic acid) (PLGA) nanoparticles by an enhanced mixing in 3D microchannels. As-prepared PLGA nanoparticles with ≈100 nm have optimum interactions with cell membrane and realize a significantly improved cellular uptake.[61,69,70]\nAnother group also reports similar results that the maxi mum NMs cellular uptake appears at a size of 100 nm.[71] In their study, dimethylaminobenzaldehyde modified PLGA nanoparticles with different sizes show notably different effects on cellular uptake. The nanoparticles with ≈100 nm have an optimal cellular uptake that possibly be explained that 100 nm size has the optimized nanointerface between nanoparticles and cell membrane and forms the strong NMs–cell interaction force.[71] Furthermore, other several studies explain why 100 nm is an optimized size for the cellular uptake of NMs. They report that the large particle size (≈100 nm), based on carboxymethyl chitosan grafted nanoparticles and chitosan hydrochloride grafted nanoparticles, tends to be phagocytized by cells. Although slight differences of both particle sizes and cell lines will cause some interference more or less in NMs cellular uptake,[72] small size NMs (smaller than 50 nm), in usual cases, have less ligands-to-receptors interactions than their larger partners. For these small size NMs, it is necessary to convene several small ones to simultaneously interact with cell membrane receptors in close proximity to trigger membrane wrapping. By contrast, large size (≈100 nm) NMs can better act as the cross-linking agents to bind with cluster receptors on cell membrane and induce NMs cellular uptake.[62] Moreover, thermodynamical analysis also shows that ≈100 nm NMs can easily recruit enough receptors to successfully trigger the cellular internalization of NMs.[73]\nHowever, all abovementioned studies are achieved in an ideal condition, such as the aqueous solution or a simple saline solution. In the complex physiological conditions,[61] the real size of NM should contain both the diameter of NM itself and the thickness of PC (we have described this concept in details in preceding paragraphs) on NM surface. Once exposed to physiological environment, NMs will inevitably contact with a huge variety of biomolecules and adsorb some of these molecules. Such absorption will greatly affect the final size of NMs (we call the size of NMs in physiological conditions as biological size),[59] which finally affects the cellular membrane response and regulates NMs cellular uptake.[66]\nAccording to above descriptions, a key point to investigate the effect of NMs size on their cellular uptake in vivo is to precisely measure the thickness of PC on the surface of naked NMs. However, it is still lacking one satisfactory method to measure or at least predict the thickness of PC. This is one of the biggest bottlenecks to impede researching the size effects of NMs on their cellular uptake in vivo. Moreover, we also should note that NMs cellular uptake is dynamic. It depends on a variety of factors, including the relative concentration between NMs and components in the surrounding media and the affinity between cellular biomolecules/membranes and NMs.[67] Moreover, since NMs cellular uptake is an evolving and dynamic process that must adapt to varying concentrations of biomolecules presented in the fluid,[68] such a dynamic behavior undoubtedly makes the investigation of in vivo cellular uptake of NMs more difficult and complex. Even so, a recent study still opens up a gleam of light for investigating the size effects of NMs on affecting their cellular uptake in vivo. Prosperi and co-workers prepared two types of gold nanoparticles with different sizes via linking different numbers of targeting antibodies (either one\nSmall 2017, 1701815\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1701815 (5 of 13)\nantibody or two antibodies) on the surface of gold nanoparticles. By means of confocal laser scanning micrographs (single optical sections), they directly observed cryosections of tumors and successfully measured the numbers and localization of NMs engulfed by cells in vivo.[74] This study reminds us that (1) choosing the suitable method is critical to measure NMs cellular uptake in vivo, and (2) using isolated tissues to research NMs cellular uptake in vivo may be an acceptable option. In other in vivo studies, researchers use radiolabeled technique to quantitatively analyze the cellular uptake of carbon-based nanoparticles in rats via inhalation administration. They find that the size of nanoparticles can largely determine the final biodistribution inside cells of these nanoparticles.[75] Similarly, radiolabeled gold nanoparticles with different sizes are delivered by intraoesophageal instillation in rats. The smallest (≈1.4 nm) nanoparticles with negative surface charges have the best cellular uptake and the highest accumulation in most secondary organs, except brain and heart where 18 nm nanoparticles show a higher quantity.[76] Moreover, a systematic assessment for the role of hydrodynamic size in affecting NMs cellular uptake is performed in rat model based on the near-infrared fluorescence tracing. The researchers find that NPs with a hydrodynamic size of less than 34 nm can better be uptake by cells.[77] Therefore, NMs with less than 34 nm (even 1.4 nm) seem to have an optimized cellular uptake in vivo.\nMoreover, the agglomeration or aggregation of NMs under physiological conditions further poses a challenge to investigate the relevance between NMs size and NMs cellular uptake in vivo. It is exceedingly difficult to quantitatively characterize the details of NMs agglomeration/aggregation in vivo using conventional techniques such as nanoparticle tracking analysis, electron microscopy imaging, and dynamic light scattering, since such techniques only can confirm the presence of NMs agglomeration/aggregation in vivo or give a general size distribution of NMs agglomeration/aggregation in vitro.[78–80] Even so, a recent study still provides us some interesting data to uncover the correlation between NMs agglomeration and cellular uptake in a mimic in vivo environment.[80] Parak and co-workers design a series of gold–polymer core–shell nanoparticles of the sizes that can be regulated via temperaturedependent agglomerations. By investigating the correlation between nanoparticle size and their cellular uptake, the authors find that nanoparticle agglomeration significantly change the size of nanoparticles to affect their cellular uptake. They also further find that, in various cells lines, the cellular uptake of nanoparticles is determined by the size of agglomeration, regardless of their agglomeration patterns (thermosensitive or non-thermosensitive agglomeration).[80]\nOverall, although it is clear that the size of NMs has a strong effect on their cellular uptake in vitro,[61,69] it still faces many difficulties to quantitatively identify the relevance between size and cellular uptake in vivo. This may be due to the huge varieties of NMs and the complexity of in vivo environments that cause difficulties to draw a general conclusion from the huge pool of available data. Encouragingly, there is still some consensus that has been accepted and generalized for NMs cellular uptake. (1) There is an optimal size (≈100 nm) for efficient NMs cellular uptake independent of particle composition. (2) Choosing the suitable researching model is important to\nactually uncover NMs cellular uptake in vivo. (3) Developing advanced methods and technologies to effectively measure the thickness of PC is a fundamental solution to bridge the correlation between in vitro and in vivo for researching the size effects of NMs on their cellular uptake."
    }, {
      "heading" : "5. Rigidity",
      "text" : "So far, fewer studies focus specifically on investigating how the rigidity of NMs regulates NMs cellular uptake. The rigidity, or the stiffness, is one of the critical physical principles that govern the interactions between NMs and cells. NMs, based on their degree of rigidity, are also usually divided into the soft and hard ones. The former usually includes the polymeric and lipidic NMs and the latter mainly contains metallic and ceramic NMs.[81–84] For soft NMs, such as lipids-based NMs (vesicles, liposomes, micelles, and polymeric capsules), their surface will deform once interacting with cell membrane. During the whole process of NMs cellular uptake, the total deformation energy of NMs for their entry into cell membrane will also dynamically alter. Such changes give rise to different kinetics of NMs– cell membrane interactions. The study for the effect of NMs rigidity on regulating their cellular uptake usually requires a good understanding and calculation for NMs–cell membrane kinetics.[85]\nMultiple theoretical and experimental models have shown that the interactions between NMs and cells are very sensitive to the relative rigidity of NMs toward cell membrane. Hard NMs can achieve full wrapping easier than their soft partners.[82,83,86] The elasticity effect mediating the interactions between NMs and cell membrane has been precisely identified via investigating the cell uptake of spherical solid nanocapsules and (2D cylindrical) nanorods. Solid nanocapsules require less adhesion energy (γmin, its average value is more than 4) to achieve full wrapping than their fluidic vesicular analogues with similar bending stiffness (κm) which ranges from 20 kBT to 150 kBT (1 kBT = 4.11 × 10−21 J).[87] The question on how soft NMs stably interact with cell membrane can be explained by calculating the contact angle of soft NMs. A softer nanoparticle means a larger wetting angle, thereby resulting in a higher extent of spreading between nanoparticle and cell membrane. The highly spread NMs will form the large curvatures at the spreading front. Furthermore, wrapping NMs need to overcome a large bending energy barrier which is inherent to the spread shape of NMs. A previous study shows that a sufficiently large energy barrier needs to be defeated in order to completely finish the wrapping of NMs by cell membrane.[85]\nA theoretical calculation also shows that the rigidity of NMs plays a critical role in affecting NMs cellular uptake.[82] The kinetics of receptor-mediated endocytosis of elastic nanoparticles would be limited by the diffusion of receptors, and largely depends on the rigidity of nanoparticles, the cellular membrane tension, and the binding strengths between membrane receptors and ligands grafted on the surface of nanoparticle. Soft NMs are less prone to be fully wrapped than hard ones. It has been suggested that the wrapping of harder NMs is kinetically faster than that of soft ones. Moreover, by investigating the correlation between cellular uptake and rigidity of spherical\nSmall 2017, 1701815\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1701815 (6 of 13)\nand cylindrical elastic nanoparticles, researchers find that receptor–ligand binding amount (the average binding energy per receptor–ligand bond ranges from 10 kBT to 25 kBT) during the process of endocytosis of elastic nanoparticles is also an important factor to determine the rigidity-mediated NMs cellular uptake.[88]\nRecently, our group carried out several works about the rigidity-mediated NMs cellular uptake. We developed a twostage microfluidic chip to produce a series of core–shell PLGAlipid nanoparticles with the same chemical composition, size, and surface properties, but varying rigidity (Young’s modulus range from 1.20 ± 0.11 GPa to 0.76 ± 0.07 GPa). In both HeLa cell (a type of cancer cell line) and human umbilical vein endothelial cell (HUVEC) models, these nanoparticles with varying rigidity are employed to understand how the rigidity of nanoparticles regulates the cellular uptake of nanoparticles and elucidate its intrinsic mechanism (Figure 2). Our experiments suggest that the rigidity can dramatically alter the cellular uptake of nanoparticles. More rigid nanoparticles (Youngs modulus is 1.20 ± 0.11 GPa) can enter HeLa and HUVEC cell membrane more easily.[82]\nOnce exposing to biological environments such as blood, the rigidity of NMs will significantly differ from their intrinsic\nstatus.[21,46,89] In vivo, biomolecules or proteins will rapidly absorb on NMs surface form a transient layer conceptualized as a loosely associated/dynamic coating.[46,90] Such a dynamic coating usually makes NMs softer. The effect of softer coating on NMs cellular uptake still remains vague.[21] To better investigate the effects of rigidity on NMs cellular uptake in vivo, we should introduce a putative concept of absorption ratio. Absorption ratio that can be theoretically defined as the quantity of absorbed biological proteins. An important consequence is reported that such a protein ratio is positively correlated with the percentage of serum proteins.[91] This study offers us an important implication that translating the rigidity of NMs into the content of serum proteins may be reasonable for investigating the rigidity effects of NMs on their cellular uptake in vivo.\nAnother study provides us a new thinking to understand how the rigidity of NMs affects their cellular uptake in vivo. Based on the fluorescence-labeling technology, the researchers investigate the role of the rigidity of substrate on cellular uptake using polyacrylamide hydrogel as a model substrate with tunable rigidity. The relationship between the rigidity of substrate and the cellular uptake of fluorescent nanoparticles by bovine aortic endothelial cells shows that a stiffer substrate can result\nSmall 2017, 1701815\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1701815 (7 of 13)\nin a higher total cellular uptake. It suggests that the stiffer ones may also facilitate NMs cellular uptake. By using thermodynamic model to uncover underlying mechanism of cellular uptake, the authors predict that both membrane spreading area and cell membrane tension are two key factors to control NMs cellular uptake, which in turn are modulated by the rigidity of NMs.[92]\nOverall, rigidity is an important physicochemical parameter to alter NMs cellular uptake. Considering the surface rigidity of NMs will more significantly determine their cellular uptake than the core rigidity of NMs, and understanding the components and dynamic interactions of PC on NMs surface should be put into a forward position. Moreover, combining fluorescence-labeling technology with thermodynamic model possibly is a suitable strategy to investigate the rigidity effect of NMs on their cellular uptake in vivo."
    }, {
      "heading" : "6. Shape",
      "text" : "In comparison with size and rigidity, shape suffers relatively less influence caused by complex factors in physiological environment. As far as we know, few studies report that the shape of NMs has a fundamental change when NMs enter the body,\nexcept in the case of self-aggregation of NMs. Therefore, the shape effect of NMs on their cellular uptake can be relatively easier to be explored.[93–95] Our recent research shows that silver nanospheres allow more cellular uptake than nanorods. We synthesize two types of silver NMs with the same surface modification of polyvinylpyrrolidone (PVP) and polyethylene glycol (PEG), diameter (60 nm), charge (−11 mV), and size/volume, but different shapes (rod and sphere). By inductively coupled plasma spectroscopy and transmission electron microscope, we observe that the uptake of nanorods by Hela and HUVEC cell lines are far less than nanospheres in a broad concentration range (Figure 3).[96] Such a result is also indirectly verified in vivo via evaluating the toxicity of NMs that is correlated with NMs cellular uptake.\nNanofibers, a type of NMs with higher aspect ratio than nanorods, have shown their potential for regulating the cellular uptake.[97] Some reports show that nanofibers can effectively sense and manipulate the functions and behaviors of cells with a minimal perturbation.[98,99] However, so far, the cellular uptake of nanofibers remains to be somewhat difficult to understand, mainly because many results in the literature about the interactions between nanofibers and cells conflict one another. For example, there is a totally different distribution of retinal cells between the flat substrate and nanofiberic substrate. Such\nSmall 2017, 1701815\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1701815 (8 of 13)\ndifference of cell distribution reveals that cells possibly detach from flat substrate, instead of forming a nanofiber substrate, due to a stronger cell adhesion on nanofibers.[100] By contrast, another similar study does not find any significant differences in the distribution of HepG2 cells between flat substrate and nanofiber even after a 48 h culturing.[101] Similar conflicting conclusion is also mentioned in other studies.[102] The difference of cell type may explain these contradictory results. Indeed, primary cortical astrocytes can better adhere to short nanofibers (≈0.2 µm), whereas immortalized astrocytes (LRM55 cells) tend to attach on flat regions.[103] This study thereby stresses the importance of cell type on affecting interactions between nanofibers and cells. Moreover, for human mesenchymal stem cells, researchers measure an increasing expression of pFAK and vinculin protein which are cellular adhesion molecules on relatively short nanofibers (10–15 µm), compared with longer nanofibers (20–25 µm). Another group uses HEK293 cells as a rinsing assay and find that cell detachment is of lesser extent on nanofiber substrates.[104] All these results suggest that there is still some interference on interactions between nanofibers and cells, even for the same composition of nanofibers.\nEven so, one recent study in our group shows a new finding for the cellular uptake of nanofibers.[11] Unintentionally, we find the difference of DNA packaging capability between lefthanded and right-handed peptidic nanofibers. The results from circular dichroism spectrum and transmission electron microscopy show that only left-handed peptidic nanofibers, instead of right-handed peptidic nanofibers, can package DNA into a highly condensed structure. Considering the condensation status of DNA can significantly increase the uptake efficiency of DNA by mammalian cells,[105–107] we further evaluate the cellular uptake efficiency of peptidic nanofibers in vitro. Enhanced green fluorescent protein (EGFP)-expressing plasmid is delivered using peptidic nanofibers into cells. EGFP shows that left-handed peptidic nanofibers show a significantly higher DNA delivery level than right-handed peptidic nanofibers. The maximal expression efficiency of EGFP assisted by left-handed peptidic nanofibers is 30.38–36.60%,\nwhile the expression efficiency of EGFP assisted by lefthanded peptidic nanofibers is only <1%, which is similar to the naked DNA.[11] Furthermore, significantly enhanced immune responses induced by DNA delivered by left-handed peptidic nanofibers are also detected in vivo, showing an indirect evidence that left-handed peptidic nanofibers have a higher cellular uptake than right-handed ones in vivo. Therefore, our research offers a solid evidence that the chirality of nanofibers will affect their cellular uptake in vitro and in vivo (Figure 4)."
    }, {
      "heading" : "7. Surface Modification",
      "text" : "Whenever NMs contact with cells, the first interaction is dependent on the surface modification of NMs.[108,109] It has been fully demonstrated that the surface modification of NMs can significantly affect NMs cellular uptake in vitro. For example, using 40 and 80 nm gold nanoparticles, researchers investigate the role of surface modification in affecting NMs cellular uptake in HUVEC and liver cells. Gold nanoparticles are coated with branched polyethyleneimine, lipoic acid or PEG. By proteomic analysis on the surface chemistry-dependent signature adsorbates, researchers find that human serum albumin (HSA) can more easily form corona on NMs surface than human plasma protein (HP). Time-dependent cellular uptake detection shows that HSA corona-bound gold nanoparticles have significant reduction in cellular uptake compared with HP corona-bound ones.[110] Another interesting report shows that gold-based NMs with the same chemical composition but different surface modification have totally different cell membrane response. NMs with an ordered chemical modification could better go through cell membrane without disrupting the phospholipid bilayer. By contrast, those with a random chemical modification are mostly trapped in endosomes.[111] These works show that surface modification can significantly determine the biocorona composition and affect biocorona-mediated cellular uptake.\nSmall 2017, 1701815\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1701815 (9 of 13)\nOur group has developed a series of surface modification strategies to control the interactions between cells and NMs, including azobenzene-embedded self-assembled surface modification, alkanethiol coating, poly(dimethylsiloxane)-based silane coating, glass-based poly(ethylene glycol)-terminated oxysilane (PEG-oxysilane) corona, and self-polymerized dopamine covering.[112–121] One of our representative works reports a method for the reversible control of cell adhesion on a molecularly well-defined NMs.[120] We modify NMs with azobenzene units to reversibly present the ligand consisting of arginine–glycine–aspartate (RGD) peptides on self-assembled monolayers (SAMs). SAMs allow us to design and quickly obtain a molecularly well-defined nanoscale surface that can reversibly control cell adhesion. Such a surface can controllably accommodate or resist the cell adhesion depending on the conformation of azobenzene embedded in SAMs. Because cellular uptake essentially starts at cell adhesion, we believe that, by combining with the ability to spatially address surface modification, the uptake behaviors of a single cell or a group of cells (such as neurites) can be precisely controlled (Figure 5).[120]\nRegulating the quantity of surface modification is an effective strategy to optimize NMs cellular uptake. In another study from our group, silver-based NMs are modified by both PVP and PEG.[96] Surface modification of NMs with PEG or PVP is considered to be a real breakthrough to avoid the recognition and phagocytosis of macrophage, thereby improving the retention and prolonging the circulation cycle of NMs in vivo.[122–124] Since the molecules coated on NMs surface can induce polyvalent effects to improve cell adhesion,[125] PVP–PEG surface modification will increase NMs cellular uptake. We precisely identify the ratio between PVP and PEG on NMs surface. The result shows a 1:2.7 ratio of PVP:PEG has an optimized cellular\nuptake by the evaluation using inductively coupled plasma spectroscopy and transmission electron microscopy. It suggests that the quantity of surface modification is critical to control NMs cellular uptake.[96]\nHowever, once NMs enter the body, the initial cellular uptake mediated by surface modification of NMs possibly significantly changes.[16] In physiological environments, NMs interact with proteins, membranes, cells, DNA, and organelles to re-establish a series of dynamic surface modifications. Some data even suggest that the surface modification of NMs plays a dominant role over size in determining NMs cellular uptake and subsequent cytobiological responses.[47] For investigating the correlation between surface modification and NMs cellular uptake in vivo, we think, NMs-labeling strategy may be the best option to date.[126] Radioactive labeling shows its great value for in vivo monitoring the uptake, transport, and distribution of NMs. This technology has already been employed to trace the cellular uptake of Au-based and Fe-based NMs in vivo.[40–42] X-ray, MRI, and fluorescence imaging also have shown the similar function on observing NMs cellular uptake in vivo, although they possess relatively weaker capability for detecting absolute cellular uptake amounts of NMs.[37–39] For example, researchers use in situ small-angle X-ray scattering to track in vivo cellular uptake of porous metal–organic frameworks (MOFs), a type of star NMs widely used for researching NMs–cells interactions.[127–130] The results show that the initial adsorption between MOFs and cells mainly determines NMs cellular uptake efficiency. Moreover, via covalent-linking MOF nanoparticles with some fluorescence-labeled polymers, researchers investigate the cellular uptake of MOF nanoparticles in tumor models, and find that poly(ethylene glycol) chains surface modification enhances the selectivity of NMs cellular uptake between cancerous cells\nSmall 2017, 1701815\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1701815 (10 of 13)\nand healthy cells, possibly due to more acidic cancerous cell microenvironment.[131,132] Considering that cells regulate their uptake behaviors via a series of procedures of cellular signaling pathways which are often induced by the binding between cell surface receptors and their corresponding ligand molecules, researchers explore how antibodies-modified NMs regulate the process of membrane receptor internalization.[133] Gold nanoparticles ranging from 2 to 100 nm and modified by herceptin (antiovarian/breast cancer monoclonal antibody) are used to investigate interactions between herceptin-modified NMs and ErbB2 receptors (overexpressed on ovarian/breast cancer cells). Compared with naked gold nanoparticles, the herceptin-modified NMs show significantly enhanced cellular uptake after being incubated with human breast cancer cells in vivo and better control the growth of tumor.[133] The authors also further prove that herceptin modification can positively and selectively induce the expression of membrane receptor to regulate the subsequent cellular uptake.[133] Similarly, several studies on quantum dots (QDs), such as semiconductor nanocrystals, also provide us good examples about how surface modification interferes the interactions between NMs and cells. The superior optical properties of QDs, such as tunable emission spectra, minimal photobleaching, high fluorescence efficiency, and constant excitation wavelength, pave the way to analyze in vivo cellular adhesion and uptake.[134,135] Highly fluorescent QDs have been used for tracing in vivo cellular uptake kinetics of vascular endothelial cells in liver via intravital fluorescence microscopy.[136] Moreover, poly(dl-lactide-co-glycolide) nanoparticles carrying conjugated polymers with p-conjugated backbones can produce strong fluorescence. Such nanoparticles can effectively trace their cellular uptake process in human breast cancer model.[137,138] Similarly, another study uses calcium phosphate nanoparticles (a type of natural material broadly distributed in bones and teeth) modified with nearinfrared fluorescence to successfully tracing the cellular uptake of nanoparticles in human breast cancer tumors.[139]\nOverall, surface modifications will significantly determine NMs cellular uptake via affecting the interactions between NMs and cells. Actually, compared with other parameters such as size, shape, and rigidity, surface modifications can be more flexibly manipulated to control NMs cellular uptake. More importantly, surface modification is the basis for realizing NMs-labeling technologies that are viewed as the best option so far to analyze in vivo NMs cellular uptake. Thus, developing advanced surface modification technologies will possibly become the point of penetration to conquer the challenges for researching in vivo NMs cellular uptake."
    }, {
      "heading" : "8. Summary and Outlook",
      "text" : "In this Review, we discuss several important physicochemical properties of NMs on regulating their cellular uptake including size, rigidity, shape, and surface modifications. Generally speaking, NMs cellular uptake is the first and critical step for triggering the following biomedical functions and responses. Understanding NMs cellular uptake in depth will effectively guide us how to optimize biomedical behaviors and effects of NMs. Existing experimental findings indeed provide us some useful information but are still far from precisely predicting the\neffects of physicochemical properties on NMs cellular uptake in vivo. A major bottleneck, we think and are facing, is the lack of some advanced probing technologies and methodology to real-time and quantitative observation of NMs cellular uptake in vivo. The development of those probing technologies to characterize in vivo NMs cellular uptake will bring the major breakthrough in the future. Considering huge differences of NMs cellular uptake between in vitro and in vivo, developing advanced methods or theoretical models to uncover the relevance between in vitro and in vivo is another important issue. Also, constructing in vitro systems that can truthfully mimic in vivo microenvironments will help us to more conveniently understand the actual in vivo NMs cellular uptake. Moreover, since the formation of PC not only changes the size and rigidity of NMs but also partly masks the functional surface modifications of NMs,[140,141] exploring the formation mechanism of PC and establishing reasonable bio-nanomaterial interaction model should be able to help us to better understand the transformation of NMs functions in vivo in further research.\nMoreover, although we focus on discussing NMs cellular uptake in this review, we also need to further think about the subsequent questions: What happens after NMs cellular uptake? Where they go? What are the impacts of intracellular NMs on cell functions? Actually, any NMs once entering cells are subjected to one or more intracellular processing pathways/ mechanisms. The cellular actions of intracellular NMs may involve erosion, deagglomeration, disintegration, dissolution, or chemical/biological degradation, finally going to NMs cellular excretion.[142–149] In turn, intracellular NMs can also affect various cellular activities or behaviors including turn-on/off of signaling pathways, up/down-regulation of gene expression, cell proliferation, and cell migration in vivo.[150,151] More importantly, many research methods of NMs cellular uptake abovementioned in this Review can be spotaneously switched to study intracellular NMs behaviors and fate, such as subcellular localization, intracellular trafficking, intracellular process, and release. All these will finally determine NMs biological effects in vivo. Therefore, this review will possibly provide the valuable summaries and thinking in a borader range of NMs biological research, instead of only in the field of NMs cellular uptake."
    }, {
      "heading" : "Acknowledgements",
      "text" : "Y.L. and B.W. contributed equally to this work. This work was financially supported by the National Science Foundation of China (Grant Nos. 31500816, 81361140345, 51373043, 21535001, and 81501790), the Ministry of Science and Technology of China (Grant No. 2013YQ190467), and Chinese Academy of Sciences (Grant No. XDA09030305).\nConflict of Interest The authors declare no conflict of interest.\nKeywords cellular uptake, nanomaterials, physicochemical properties\nReceived: May 31, 2017 Revised: July 31, 2017\nPublished online:\nSmall 2017, 1701815\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1701815 (11 of 13)\n[1] K. Riehemann, S. W. Schneider, T. A. Luger, B. Godin, M. Ferrari, H. Fuchs, Angew. Chem. Int. Ed. 2009, 48, 872. [2] M. M. Kemp, R. J. Linhardt, WIREs Nanomed. Nanobiotechnol. 2010, 2, 77. [3] D. J. Evans, Inorg. Chim. Acta 2010, 363, 1070. [4] B. Roldan Cuenya, Thin Solid Films 2010, 518, 3127. [5] S. Cheng, Y. Jin, N. Wang, F. Cao, W. Zhang, W. Bai, W. Zheng,\nX. Jiang. Adv Mater. 2017, 29, 1700171. [6] H. M. Hiep, H. Yoshikawa, M. Saito, E. Tamiya, ACS Nano 2009,\n3, 446. [7] A. Ruiz-de-Angulo, A. Zabaleta, V. Gómez-Vallejo, J. Llop,\nJ. C. Mareque-Rivas, ACS Nano 2016, 10, 1602. [8] N. L. Rosi, D. A. Giljohann, C. S. Thaxton, A. K. Lytton-Jean,\nM. S. Han, C. A. Mirkin, Science 2006, 312, 1027. [9] Y. Liu, Y. Xu, Y. Tian, C. Chen, C. Wang, X. Jiang, Small 2014, 10,\n4505. [10] Y. Liu, H. Wang, D. Li, Y. Tian, W. Liu, L. Zhang, W. Zheng, Y. Hao,\nJ. Liu, Z. Yang, Y. Shao, X. Jiang, Nanoscale Horiz. 2016, 2016, 135. [11] Y. Tian, H. Wang, Y. Liu, L. Mao, W. Chen, Z. Zhu, W. Liu,\nW. Zheng, Y. Zhao, D. Kong, Z. Yang, W. Zhang, Y. Shao, X. Jiang, Nano Lett. 2014, 14, 1439. [12] A. A. Date, C. J. Destache, Biomaterials 2013, 34, 6202. [13] C. C. Fleischer, C. K. Payne, Acc. Chem. Res. 2014, 47, 2651. [14] T. S. Hauck, A. A. Ghazani, W. C. Chan, Small 2008, 4, 153. [15] D. J. Brayden, S. A. Cryan, K. A. Dawson, P. J. O’Brien,\nJ. C. Simpson. Drug Discovery Today 2015, 20, 942. [16] A. E. Nel, L. Madler, D. Velegol, T. Xia, E. M. Hoek,\nP. Somasundaran, F. Klaessig, V. Castranova, M. Thompson, Nat. Mater. 2009, 8, 543. [17] N. Feliu, D. Docter, M. Heine, P. Del Pino, S. Ashraf, J. Kolosnjaj-Tabi, P. Macchiarini, P. Nielsen, D. Alloyeau, F. Gazeau, R. H. Stauber, W. J. Parak. Chem. Soc. Rev. 2016, 45, 2440. [18] P. RiveraGil, D. Jimenez de Aberasturi, V. Wulf, B. Pelaz, P. del Pino, Y. Zhao, J. de la Fuente, I. Ruiz de Larramendi, T. Rojo, X. Liang, W. J. Parak, Acc. Chem. Res. 2013, 46, 743. [19] B. Pelaz, G. Charron, C. Pfeiffer, Y. L. Zhao, J. M. de la Fuente, X. J. Liang, W. J. Parak, P. del Pino, Small 2013, 9, 1573. [20] W. J. Parak, D. Gerion, T. Pellegrino, D. Zanchet, C. Micheel, S. C. Williams, R. Boudreau, M. A. L. Gros, C. A. Larabell, A. P. Alivisatos, Nanotechnology 2003, 14, R15. [21] D. Docter, D. Westmeier, M. Markiewicz, S. Stolte, S. K. Knauer, R. H. Stauber, Chem. Soc. Rev. 2015, 44, 6094. [22] H. Hillaireu, P. Couvreur, Cell. Mol. Life Sci. 2009, 66, 2873. [23] Y. Yan, K. T. Gause, M. M. Kamphuis, C. S. Ang,\nN. M. O’Brien-Simpson, J. C. Lenzo, E. C. Reynolds, E. C. Nice, F. Caruso, ACS Nano 2013, 7, 10960. [24] B. M. Rothen-Rutishauser, S. Schurch, B. Haenni, N. Kapp, P. Gehr, Environ. Sci. Technol. 2006, 40, 4353. [25] D. A. Kuhn, D. Vanhecke, B. Michen, F. Blank, P. Gehr, A. Petri-Fink, B. Rothen-Rutishauser, Beilstein J. Nanotechnol. 2014, 5, 1625. [26] A. I. Ivanov, Methods Mol. Biol. 2008, 440, 15. [27] M. Calero, M. Chiappi, A. Lazaro-Carrillo, M. J. Rodriguez,\nF. J. Chichon, K. Crosbie-Staunton, A. Prina-Mello, Y. Volkov, A. Villanueva, J. L. Carrascosa, J. Nanobiotechnol. 2015, 13, 16. [28] E. M. Luther, Y. Koehler, J. Diendorf, M. Epple, R. Dringen, Nano technology 2011, 22, 375101. [29] K. Chen, X. Li, H. Zhu, Q. Gong, K. Luo, Curr. Med. Chem. 2017, 24, https://doi.org/10.2174/0929867324666170428153056. [30] a) X. Lu, T. Zhu, C. Chen, Y. Liu, Int. J. Mol. Sci. 2014, 15, 17577; b) H. M. Mansour, Y-S. Rhee, X. Wu, Int. J. Nanomed. 2009, 4, 299. [31] V. D. Mridula, K. H. Rakesh, O. Koshkina, M. Maskos, H. J. Galla, Biophys. J. 2014, 106, 289.\n[32] X. Lin, Y. Zuo, N. Gu, Sci. China Mater. 2015, 58, 28. [33] G. Hu, B. Jiao, X. Shi, R. P. Valle, Q. Fan, Y. Zuo, ACS Nano 2013,\n7, 10525. [34] K. Yamashita, Y. Yoshioka, K. Higashisaka, K. Mimura, Y. Morishita,\nM. Nozaki, T. Yoshida, T. Ogura, H. Nabeshi, K. Nagano, Y. Abe, H. Kamada, Y. Monobe, T. Imazawa, H. Aoshima, K. Shishido, Y. Kawai, T. Mayumi, T. S-i, N. Itoh, T. Yoshikawa, I. Yanagihara, S. Saito, Y. Tsutsumi, Nat. Nanotechnol. 2011, 6, 321. [35] L. Geraets, A. Oomen, P. Krystek, N. Jacobsen, H. Wallin, M. Laurentie, H. Verharen, E. Brandon, W. de Jong, Part. Fibre. Toxicol. 2014, 11, 30. [36] B. van Ravenzwaay, R. Landsiedel, E. Fabian, S. Burkhardt, V. Strauss, L. Ma-Hock, Toxicol. Lett. 2009, 186, 152. [37] A. Moore, E. Marecos, J. A. Bogdanov, R. Weissleder, Radiology 2000, 214, 568. [38] J. R. McCarthy, R. Weissleder, Adv. Drug Delivery Rev. 2008, 60, 1241. [39] M. G. Harisinghani, K. S. Jhaveri, R. Weissleder, W. Schima, S. Saini, P. F. Hahn, P. R. Mueller, Clin. Radiol. 2001, 56, 714. [40] W. G. Kreyling, S. Hirn, W. Müller, C. Schleh, A. Wenk, G. Celik, J. Lipka, M. Schäffler, N. Haberl, B. D. Johnston, R. Sperling, G. Schmid, U. Simon, W. J. Parak, M. Semmler-Behnke, ACS Nano 2014, 8, 222. [41] B. Freund, U. I. Tromsdorf, O. T. Bruns, M. Heine, A. Giemsa, A. Bartelt, S. C. Salmen, N. Raabe, J. Heeren, H. Ittrich, R. Reimer, H. Hohenberg, U. Schumacher, H. Weller, P. Nielsen, ACS Nano 2012, 6, 7318. [42] D. Bargheer, J. Nielsen, G. Gebel, M. Heine, S. C. Salmen, R. Stauber, H. Weller, J. Heeren, P. Nielsen, Beilstein J. Nano technol. 2015, 6, 36. [43] E. Polo, M. Collado, B. Pelaz, P. Del Pino, ACS Nano 2017, 11, 2397. [44] C. Carrillo-Carrion, M. Nazarenus, S. Sánchez Paradinas, S. Carregal-Romero, M. J. Almendral, M. Fuentes, B. Pelaz, P. del Pino, I. Hussain, M. J. D. Clift, B. Rothen- Rutishauser, X. Liang, W. J. Parak, Curr. Opin. Chem. Eng. 2014, 4, 88. [45] T. Cedervall, I. Lynch, S. Lindman, T. Berggård, E. Thulin, H. Nilsson, K. A. Dawson, S. Linse, Proc. Natl. Acad. Sci. USA 2007, 104, 2050. [46] C. D. Walkey, W. C. W. Chan, Chem. Soc. Rev. 2012, 41, 2780. [47] S. T. Yang, Y. Liu, Y. W. Wang, A. Cao, Small 2013, 9, 1635. [48] M. P. Monopoli, F. B. Bombelli, K. A. Dawson, Nat. Nanotechnol.\n2011, 6, 11. [49] A. Lesniak, F. Fenaroli, M. P. Monopoli, C. Aberg, K. A. Dawson,\nA. Salvati, ACS Nano 2012, 6, 5845. [50] K. Ogawara, K. Furumoto, S. Nagayama, K. Minato, K. Higaki,\nT. Kai, T. Kimura, J. Controlled Release 2004, 100, 451. [51] G. Baier, C. Costa, A. Zeller, D. Baumann, C. Sayer, P. H. Araujo,\nV. Mailander, A. Musyanovych, K. Landfester, Macromol. Biosci. 2011, 11, 628. [52] P. J. Smith, M. Giroud, H. L. Wiggins, F. Gower, J. A. Thorley, B. Stolpe, J. Mazzolini, R. J. Dyson, J. Z. Rappoport, Int. J. Nanomed. 2012, 7, 2045. [53] P. C. Patel, D. A. Giljohann, W. L. Daniel, D. Zheng, A. E. Prigodich, C. A. Mirkin, Bioconjugate Chem. 2010, 21, 2250. [54] A. Lesniak, A. Campbell, M. P. Monopoli, I. Lynch, A. Salvati, K. A. Dawson, Biomaterials 2010, 31, 9511. [55] G. Caracciolo, L. Callipo, S. C. De Sanctis, C. Cavaliere, D. Pozzi, A. Lagana, Biochim. Biophys. Acta 2010, 1798, 536. [56] K. Nambara, K. Niikura, H. Mitomo, T. Ninomiya, C. Takeuchi, J. Wei, Y. Matsuo, K. Ijiro, Langmuir 2016, 32, 12559. [57] E. A. Sykes, Q. Dai, C. D. Sarsons, J. Chen, J. V. Rocheleau, D. M. Hwang, G. Zheng, D. T. Cramb, K. D. Rinker, W. C. Chan, Proc. Natl. Acad. Sci. USA 2016, 113, E1142.\nSmall 2017, 1701815\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1701815 (12 of 13)\nSmall 2017, 1701815\n[58] H. Dong, H. S. Parekh, Z. P. Xu, J. Colloid Interface Sci. 2015, 437, 10. [59] S. Tenzer, D. Docter, J. Kuharev, A. Musyanovych, V. Fetz, R. Hecht, F. Schlenk, D. Fischer, K. Kiouptsi, C. Reinhardt, K. Landfester, H. Schild, M. Maskos, S. K. Knauer, R. H. Stauber, Nat. Nano technol. 2013, 8, 772. [60] X. Duan, Y. Li, Small 2013, 9, 1521. [61] J. Sun, Y. Xianyu, M. Li, W. Liu, L. Zhang, D. Liu, C. Liu, G. Hu,\nX. Jiang, Nanoscale 2013, 5, 5262. [62] T. L. Moore, L. Rodriguez-Lorenzo, V. Hirsch, S. Balog, D. Urban,\nC. Jud, B. Rothen-Rutishauser, M. Lattuada, A. Petri-Fink, Chem. Soc. Rev. 2015, 44, 6287. [63] M. V. Zyuzin, T. Honold, S. Carregal-Romero, K. Kantner, M. Karg, W. J. Parak, Small 2016, 12, 1723. [64] A. Albanese, P. S. Tang, W. C. Chan, Annu. Rev. Biomed. Eng. 2012, 14, 1. [65] O. Lunov, V. Zablotskii, T. Syrovets, C. Rocker, K. Tron, G. U. Nienhaus, T. Simmet, Biomaterials 2011, 32, 547. [66] C. D. Walkey, J. B. Olsen, H. Guo, A. Emili, W. C. Chan, J. Am. Chem. Soc. 2012, 134, 2139. [67] S. H. Hwang, F. Thielbeer, J. Jeong, Y. Han, S. V. Chankeshwara, M. Bradley, W. S. Cho, J. Toxicol. Environ. Health, Part A 2016, 79, 925. [68] I. Lynch, A. Salvati, K. A. Dawson, Nat. Nanotechnol. 2009, 4, 546. [69] X. Mu, W. Zheng, J. Sun, W. Zhang, X. Jiang, Small 2013, 9, 9. [70] L. Zhang, Q. Feng, J. Wang, J. Sun, X. Shi, X. Jiang, Angew. Chem.\nInt. Ed. 2015, 54, 3952. [71] A. Xu, M. Yao, G. Xu, J. Ying, W. Ma, B. Li, Y. Jin, Int. J. Nanomed.\n2012, 7, 3547. [72] M. V. Zyuzin, T. Honold, S. Carregal-Romero, K. Kantner, M. Karg,\nW. J. Parak, Small 2016, 12, 1723. [73] C. He, Y. Hu, L. Yin, C. Tang, C. Yin, Biomaterials 2010, 31,\n3657. [74] M. Colombo, L. Fiandra, G. Alessio, S. Mazzucchelli, M. Nebuloni,\nC. De Palma, K. Kantner, B. Pelaz, R. Rotem, F. Corsi, W. J. Parak, D. Prosperi, Nat. Commun. 2016, 7, 13818. [75] W. G. Kreyling, M. Semmler-Behnke, J. Seitz, W. Scymczak, A. Wenk, P. Mayer, S. Takenaka, G. Oberdörster, Inhalation Toxicol. 2009, 21, Suppl 1, 55. [76] C. Schleh, M. Semmler-Behnke, J. Lipka, A. Wenk, S. Hirn, M. Schäffler, G. Schmid, U. Simon, W. G. Kreyling, Nanotoxicology 2012, 6, 36. [77] H. S. Choi, Y. Ashitate, J. H. Lee, S. H. Kim, A. Matsui, N. Insin, M. G. Bawendi, M. Semmler-Behnke, J. V. Frangioni, A. Tsuda, Nat. Biotechnol. 2010, 28, 1300. [78] S. V. Sokolov, K. Tschulik, C. Batchelor-McAuley, K. Jurkschat, R. G. Compton, Anal. Chem. 2015, 87, 10033. [79] S. Mitragotri, J. Lahann, Nat. Mater. 2009, 8, 15. [80] M. V. Zyuzin, T. Honold, S. Carregal-Romero, K. Kantner, M. Karg,\nW. J. Parak, Small 2016, 12, 1723. [81] W. C. Huang, P. A. Burnouf, Y. C. Su, B. M. Chen, K. H. Chuang,\nC. W. Lee, P. K. Wei, T. L. Cheng, S. R. Roffler, ACS Nano 2016, 10, 648. [82] J. Sun, L. Zhang, J. Wang, Q. Feng, D. Liu, Q. Yin, D. Xu, Y. Wei, B. Ding, X. Shi, X. Jiang, Adv. Mater. 2015, 27, 1402. [83] X. Yi, X. Shi, H. Gao, Phys. Rev. Lett. 2011, 107, 098101. [84] Q. Feng, J. Liu, X. Li, Q. Chen, J. Sun, X. Shi, B. Ding, H. Yu, Y. Li,\nX. Jiang, Small 2017, 13, 1603109. [85] S. Zhang, H. Gao, G. Bao, ACS Nano 2015, 9, 8655. [86] H. M. Ding, Y. Q. Ma, Small 2015, 11, 1055. [87] X. Yi, H. Gao, Soft Matter 2015, 11, 1107. [88] X. Yi, H. Gao, Nanoscale 2017, 9, 454. [89] A. M. Nystrom, B. Fadeel, J. Controlled Release 2012, 161, 403. [90] P. M. Kelly, C. Aberg, E. Polo, A. O’Connell, J. Cookman, J. Fallon,\nZ. Krpetic, K. A. Dawson, Nat. Nanotechnol. 2015, 10, 472.\n[91] L. Lartigue, C. Wilhelm, J. Servais, C. Factor, A. Dencausse, J. C. Bacri, N. Luciani, F. Gazeau, ACS Nano 2012, 6, 2665. [92] C. Huang, P. J. Butler, S. Tong, H. S. Muddana, G. Bao, S. Zhang, Nano Lett. 2013, 13, 1611. [93] Y. L. Wu, N. Putcha, K. W. Ng, D. T. Leong, C. T. Lim, S. C. Loo, X. Chen, Acc. Chem. Res. 2013, 46, 782. [94] X. Huang, X. Teng, D. Chen, F. Tang, J. He, Biomaterials 2010, 31, 438. [95] E. C. Wurster, R. Liebl, S. Michaelis, R. Robelek, D. S. Wastl, F. J. Giessibl, A. Goepferich, M. Breunig, ACS Appl. Mater. Inter faces 2015, 7, 7891. [96] Y. Liu, Y. L. Balachandran, D. Li, Y. Shao, X. Jiang, ACS Nano 2016, 10, 3589. [97] S. Bonde, N. Buch-Manson, K. R. Rostgaard, T. K. Andersen, T. Berthing, K. L. Martinez, Nanotechnology 2014, 25, 362001. [98] A. K. Shalek, J. T. Gaublomme, L. Wang, N. Yosef, N. Chevrier, M. S. Andersen, J. T. Robinson, N. Pochet, D. Neuberg, R. S. Gertner, I. Amit, J. R. Brown, N. Hacohen, A. Regev, C. J. Wu, H. Park, Nano Lett. 2012, 12, 6498. [99] H. Persson, C. Kobler, K. Molhave, L. Samuelson, J. O. Tegenfeldt, S. Oredsson, C. N. Prinz, Small 2013, 9, 4006. [100] G. Piret, M. T. Perez, C. N. Prinz, Biomaterials 2013, 34, 875. [101] S. Qi, C. Yi, S. Ji, C. C. Fong, M. Yang, ACS Appl. Mater. Interfaces\n2009, 1, 30. [102] K. S. Brammer, C. Choi, S. Oh, C. J. Cobb, L. S. Connelly, M. Loya,\nS. D. Kong, S. Jin, Nano Lett. 2009, 9, 3570. [103] S. Duran, S. Novo, M. Duch, R. Gomez-Martinez,\nM. Fernandez-Regulez, A. San Paulo, C. Nogues, J. Esteve, E. Ibanez, J. A. Plaza, Lab Chip 2015, 15, 1508. [104] S. Bonde, T. Berthing, M. H. Madsen, T. K. Andersen, N. Buch-Manson, L. Guo, X. Li, F. Badique, K. Anselme, J. Nygard, K. L. Martinez, ACS Appl. Mater. Interfaces 2013, 5, 10510. [105] Z. Reich, Y. Ittah, S. Weinberger, A. Minsky, J. Biol. Chem. 1990, 265, 5590. [106] S. Choosakoonkriang, B. A. Lobo, G. S. Koe, J. G. Koe, C. R. Middaugh, J. Pharm. Sci. 2003, 92, 1710. [107] T. T. Do, V. J. Tang, J. A. Aguilera, C. C. Perry, J. R. Milligan, Biomacromolecules 2011, 12, 1731. [108] Y. Chen, Y. Xianyu, X. Jiang, Acc. Chem. Res. 2017, 50, 310. [109] K. Choi, J. E. Riviere, N. A. Monteiro-Riviere, Nanotoxicology 2017,\n11, 64. [110] P. Chandran, J. E. Riviere, N. A. Monteiro-Riviere, Nanotoxicology\n2017, 11, 507. [111] Y. Gu, W. Sun, G. Wang, M. T. Zimmermann, R. L. Jernigan,\nN. Fang, Small 2013, 9, 785. [112] M. Li, S. Wang, J. Jiang, J. Sun, Y. Li, D. Huang, Y. Z. Long,\nW. Zheng, S. Chen, X. Jiang, Nanoscale 2015, 7, 8071. [113] W. Liu, S. Xing, B. Yuan, W. Zheng, X. Jiang, Integr. Biol. 2013, 5,\n1244. [114] W. Zheng, W. Zhang, X. Jiang, Adv. Healthcare Mater. 2013, 2, 95. [115] Y. Sun, Z. Huang, W. Liu, K. Yang, K. Sun, S. Xing, D. Wang,\nW. Zhang, X. Jiang, Biointerphases 2012, 7, 29. [116] K. Sun, L. Song, Y. Xie, D. Liu, D. Wang, Z. Wang, W. Ma, J. Zhu,\nX. Jiang, Langmuir 2011, 27, 5709. [117] Z. Chen, W. Chen, B. Yuan, L. Xiao, D. Liu, Y. Jin, B. Quan,\nJ. O. Wang, K. Ibrahim, Z. Wang, W. Zhang, X. Jiang, Langmuir 2010, 26, 17790. [118] D. Wang, Y. Xie, B. Yuan, J. Xu, P. Gong, X. Jiang, Integr. Biol. 2010, 2, 288. [119] Z. Chen, Y. Li, W. Liu, D. Zhang, Y. Zhao, B. Yuan, X. Jiang, Angew. Chem. Int. Ed. 2009, 48, 8303. [120] D. Liu, Y. Xie, H. Shao, X. Jiang, Angew. Chem. Int. Ed. 2009, 48, 4406. [121] B. Yuan, Y. Li, D. Wang, Y. Xie, Y. Liu, L. Cui, F. Tu, H. Li, H. Ji, W. Zhang, X. Jiang, Adv. Funct. Mater. 2010, 20, 3715.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1701815 (13 of 13)\nSmall 2017, 1701815\n[122] I. Garcia, A. Sanchez-Iglesias, M. Henriksen-Lacey, M. Grzelczak, S. Penades, L. M. Liz-Marzan, J. Am. Chem. Soc. 2015, 137, 3686. [123] H. Braley-Mullen, J. Exp. Med. 1985, 161, 1357. [124] X. Zhi, H. Fang, C. Bao, G. Shen, J. Zhang, K. Wang, S. Guo,\nT. Wan, D. Cui, Biomaterials 2013, 34, 5254. [125] Y. Zhao, Y. Tian, Y. Cui, W. Liu, W. Ma, X. Jiang, J. Am. Chem. Soc.\n2010, 132, 12349. [126] Z. Ali, A. Z. Abbasi, F. Zhang, P. Arosio, A. Lascialfari,\nM. F. Casula, A. Wenk, W. Kreyling, R. Plapper, M. Seidel, R. Niessner, J. Knoll, A. Seubert, W. J. Parak, Anal. Chem. 2011, 83, 2877. [127] H. Sung Cho, H. Deng, K. Miyasaka, Z. Dong, M. Cho, A. V. Neimark, J. Ku Kang, O. M. Yaghi, O. Terasaki, Nature 2015, 527, 503. [128] M. Sindoro, N. Yanai, A. Y. Jee, S. Granick, Acc. Chem. Res. 2014, 47, 459. [129] I. Stassen, D. De Vos, R. Ameloot, Chemistry 2016, 22, 14452. [130] S. Li, F. Huo, Nanoscale 2015, 7, 7482. [131] A. Zimpel, T. Preiß, R. Röder, H. Engelke, M. Ingrisch, M. Peller,\nJ. O. Rädler, E. Wagner, T. Bein, U. Lächelt, S. Wuttke, Chem. Mater. 2016, 28, 3318. [132] I. Abánades Lázaro, S. Haddad, S. Sacca, C. Orellana-Tavra, D. Fairen-Jimenez, R. S. Forgan, Chem.2, 561. [133] W. Jiang, B. Y. Kim, J. T. Rutka, W. C. Chan, Nat. Nanotechnol. 2008, 3, 145. [134] E. Tholouli, E. Sweeney, E. Barrow, V. Clay, J. A. Hoyland, R. J. Byers, J. Pathol. 2008, 216, 275. [135] K. M. Tsoi, Q. Dai, B. A. Alman, W. C. Chan, Acc. Chem. Res. 2013, 46, 662. [136] M. Heine, A. Bartelt, O. T. Bruns, D. Bargheer, A. Giemsa, B. Freund, L. Scheja, C. Waurisch, A. Eychmuller, R. Reimer, H. Weller, P. Nielsen, J. Heeren, Beilstein J. Nanotechnol. 2014, 5, 1432. [137] Y. Takahashi, T. Miyamoto, H. Shiku, R. Asano, T. Yasukawa, I. Kumagai, T. Matsue, Anal. Chem. 2009, 81, 2785.\n[138] Z. Li, K. Liu, P. Sun, L. Mei, T. Hao, Y. Tian, Z. Tang, L. Li, D. Chen, J. Microencapsulation 2013, 30, 432. [139] E. I. Altinoglu, T. J. Russin, J. M. Kaiser, B. M. Barth, P. C. Eklund, M. Kester, J. H. Adair, ACS Nano 2008, 2, 2075. [140] N. Li, L. H. Peng, X. Chen, S. Nakagawa, J. Q. Gao, Vaccine 2011, 29, 6179. [141] A. Bandyopadhyay, R. L. Fine, S. Demento, L. K. Bockenstedt, T. M. Fahmy, Biomaterials 2011, 32, 3094. [142] H. Kettiger, A. Schipanski, P. Wick, J. Huwyler, Int. J. Nanomed. 2013, 8, 3255. [143] X. He, H. Nie, K. Wang, W. Tan, X. Wu, P. Zhang, Anal. Chem. 2008, 80, 9597. [144] M. Mahmoudi, H. Hofmann, B. Rothen-Rutishauser, A. Petri-Fink, Chem. Rev. 2012, 112, 2323. [145] J. Shao, H. Xie, H. Huang, Z. Li, Z. Sun, Y. Xu, Q. Xiao, X. F. Yu, Y. Zhao, H. Zhang, H. Wang, P. K. Chu, Nat. Commun. 2016, 7, 12967. [146] J. H. Park, L. Gu, G. von Maltzahn, E. Ruoslahti, S. N. Bhatia, M. J. Sailor, Nat. Mater. 2009, 8, 331. [147] M. Levy, N. Luciani, D. Alloyeau, D. Elgrabli, V. Deveaux, C. Pechoux, S. Chat, G. Wang, N. Vats, F. Gendron, C. Factor, S. Lotersztajn, A. Luciani, C. Wilhelm, F. Gazeau, Biomaterials 2011, 32, 3988. [148] T. Akagi, M. Higashi, T. Kaneko, T. Kida, M. Akashi, Biomacromole cules 2006, 7, 297. [149] K. Park, J. H. Kim, Y. S. Nam, S. Lee, H. Y. Nam, K. Kim, J. H. Park, I. S. Kim, K. Choi, S. Y. Kim, I. C. Kwon, J. Controlled Release 2007, 122, 305. [150] B. C. Evans, K. M. Hocking, M. J. Osgood, I. Voskresensky, J. Dmowska, K. V. Kilchrist, C. M. Brophy, C. L. Duvall, Sci. Transl. Med. 2015, 7, 291ra95. [151] M. Benezra, E. Phillips, M. Overholtzer, P. B. Zanzonico, E. Tuominen, U. Wiesner, M. S. Bradbury, Small 2015, 11, 1721."
    } ],
    "references" : [ {
      "title" : "Nanoscale Horiz",
      "author" : [ "Y. Liu", "H. Wang", "D. Li", "Y. Tian", "W. Liu", "L. Zhang", "W. Zheng", "Y. Hao", "J. Liu", "Z. Yang", "Y. Shao", "X. Jiang" ],
      "venue" : "2016",
      "citeRegEx" : "10",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Proc",
      "author" : [ "T. Cedervall", "I. Lynch", "S. Lindman", "T. Berggård", "E. Thulin", "H. Nilsson", "K.A. Dawson", "S. Linse" ],
      "venue" : "Natl. Acad. Sci. USA 2007, 104",
      "citeRegEx" : "45",
      "shortCiteRegEx" : null,
      "year" : 2050
    }, {
      "title" : "Int",
      "author" : [ "P.J. Smith", "M. Giroud", "H.L. Wiggins", "F. Gower", "J.A. Thorley", "B. Stolpe", "J. Mazzolini", "R.J. Dyson", "J.Z. Rappoport" ],
      "venue" : "J. Nanomed. 2012, 7",
      "citeRegEx" : "52",
      "shortCiteRegEx" : null,
      "year" : 2045
    }, {
      "title" : "Nano­ technol",
      "author" : [ "S. Tenzer", "D. Docter", "J. Kuharev", "A. Musyanovych", "V. Fetz", "R. Hecht", "F. Schlenk", "D. Fischer", "K. Kiouptsi", "C. Reinhardt", "K. Landfester", "H. Schild", "M. Maskos", "S.K. Knauer", "R.H. Stauber", "Nat" ],
      "venue" : null,
      "citeRegEx" : "59",
      "shortCiteRegEx" : "59",
      "year" : 2013
    }, {
      "title" : "ACS Nano 2008",
      "author" : [ "E.I. Altinoglu", "T.J. Russin", "J.M. Kaiser", "B.M. Barth", "P.C. Eklund", "M. Kester", "J.H. Adair" ],
      "venue" : "2",
      "citeRegEx" : "139",
      "shortCiteRegEx" : null,
      "year" : 2075
    } ],
    "referenceMentions" : [ {
      "referenceID" : 3,
      "context" : "Such absorption will greatly affect the final size of NMs (we call the size of NMs in physiological conditions as biological size),[59] which finally affects the cellular membrane response and regulates NMs cellular uptake.",
      "startOffset" : 131,
      "endOffset" : 135
    }, {
      "referenceID" : 4,
      "context" : "[137,138] Similarly, another study uses calcium phosphate nanoparticles (a type of natural material broadly distributed in bones and teeth) modified with nearinfrared fluorescence to successfully tracing the cellular uptake of nanoparticles in human breast cancer tumors.[139] Overall, surface modifications will significantly determine NMs cellular uptake via affecting the interactions between NMs and cells.",
      "startOffset" : 271,
      "endOffset" : 276
    } ],
    "year" : 2017,
    "abstractText" : "Prof. Y. Liu, Dr. B. Workalemahu, Prof. X. Jiang Beijing Engineering Research Center for BioNanotechnology CAS Key Laboratory for Biological Effects of Nanomaterials and Nanosafety CAS Center for Excellence in Nanoscience National Center for NanoScience and Technology No. 11 Zhongguancun Beiyitiao, Beijing 100190, P. R. China E-mail: xingyujiang@nanoctr.cn Prof. X. Jiang Sino-Danish College University of Chinese Academy of Sciences Beijing 100049, P. R. China",
    "creator" : "Adobe InDesign CS6 (Macintosh)"
  }
}